Literature DB >> 29126920

The 'fentanyl epidemic' in Canada - Some cautionary observations focusing on opioid-related mortality.

Benedikt Fischer1, Lenka Vojtila2, Jürgen Rehm3.   

Abstract

In Canada, opioid-related overdose mortality has steeply increased in recent years; as a substantial number of opioid-related deaths are related to fentanyl products, this phenomenon has widely been described as the 'fentanyl epidemic', also implying that these deaths are largely caused by clandestinely produced illicit fentanyl products. We examined numbers and rates of opioid- and fentanyl-related deaths in six pan-Canadian provinces with respective (coroner-based) data available from 2010 to 2016. While fentanyl-related deaths are clearly increasing from relatively low levels in all provinces, those increases are strongest in the two Western provinces (e.g., British Columbia, where fentanyl accounts for the majority of opioid deaths in 2016 and Alberta), and, to some extent, Ontario. However, fentanyl-related deaths remain a minority of deaths in Ontario (40%) and the remaining provinces (<25%). Furthermore, it is uncertain what proportion of fentanyl-related deaths is actually related to illicit fentanyl products. We conclude that fentanyl-related overdose deaths have risen - most strongly in the West - due to both a high availability of medical fentanyl products, as well as an influx of illegal fentanyl products. In most provinces, the majority of opioid deaths remain associated with other (non-fentanyl) products. Appropriate (prevention, treatment and policy) interventions need to be targeted at the full range of opioid deaths from different sources. Overall, a realistic framing of the social (e.g., media) discourse about the nature of the 'opioid overdose death crisis' is required, which is not exclusively an 'illicit fentanyl death crisis' even though this may be a socio-politically appealing image.
Copyright © 2017 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Canada; Fentanyl; Mortality; Opioids; Public health

Mesh:

Substances:

Year:  2017        PMID: 29126920     DOI: 10.1016/j.ypmed.2017.11.001

Source DB:  PubMed          Journal:  Prev Med        ISSN: 0091-7435            Impact factor:   4.018


  15 in total

1.  Psychiatry and the Opioid Crisis in Canada.

Authors:  Grainne E Neilson; Alison Freeland; Christian G Schütz
Journal:  Can J Psychiatry       Date:  2019-11-18       Impact factor: 4.356

2.  Estimation of the impacts of substance use on workplace productivity: a hybrid human capital and prevalence-based approach applied to Canada.

Authors:  Justin T Sorge; Matthew Young; Bridget Maloney-Hall; Adam Sherk; Pam Kent; Jinhui Zhao; Tim Stockwell; Katerina Perlova; Scott Macdonald; Brian Ferguson
Journal:  Can J Public Health       Date:  2019-12-02

3.  Contributions of prescribed and non-prescribed opioids to opioid related deaths: population based cohort study in Ontario, Canada.

Authors:  Tara Gomes; Wayne Khuu; Diana Martins; Mina Tadrous; Muhammad M Mamdani; J Michael Paterson; David N Juurlink
Journal:  BMJ       Date:  2018-08-29

4.  One opioid user saving another: the first study of an opioid overdose-reversal and naloxone distribution program addressing hard-to-reach drug scenes in Denmark.

Authors:  Birgitte Thylstrup; Morten Hesse; Marian Jørgensen; Henrik Thiesen
Journal:  Harm Reduct J       Date:  2019-12-05

5.  More than just availability: Who has access and who administers take-home naloxone in Baltimore, MD.

Authors:  Lauren Dayton; Rachel E Gicquelais; Karin Tobin; Melissa Davey-Rothwell; Oluwaseun Falade-Nwulia; Xiangrong Kong; Michael Fingerhood; Abenaa A Jones; Carl Latkin
Journal:  PLoS One       Date:  2019-11-07       Impact factor: 3.752

6.  Correlations between opioid mortality increases related to illicit/synthetic opioids and reductions of medical opioid dispensing - exploratory analyses from Canada.

Authors:  Benedikt Fischer; Wayne Jones; Mark Tyndall; Paul Kurdyak
Journal:  BMC Public Health       Date:  2020-01-31       Impact factor: 3.295

7.  Examining correlations between opioid dispensing and opioid-related hospitalizations in Canada, 2007-2016.

Authors:  Wayne Jones; Paul Kurdyak; Benedikt Fischer
Journal:  BMC Health Serv Res       Date:  2020-07-22       Impact factor: 2.655

Review 8.  Drug Interactions With New Synthetic Opioids.

Authors:  Clara Pérez-Mañá; Esther Papaseit; Francina Fonseca; Adriana Farré; Marta Torrens; Magi Farré
Journal:  Front Pharmacol       Date:  2018-10-11       Impact factor: 5.810

9.  An age-based analysis of nonmedical prescription opioid use among people who use illegal drugs in Vancouver, Canada.

Authors:  Tessa Cheng; Will Small; Huiru Dong; Ekaterina Nosova; Kanna Hayashi; Kora DeBeck
Journal:  Subst Abuse Treat Prev Policy       Date:  2018-11-27

Review 10.  The rising crisis of illicit fentanyl use, overdose, and potential therapeutic strategies.

Authors:  Ying Han; Wei Yan; Yongbo Zheng; Muhammad Zahid Khan; Kai Yuan; Lin Lu
Journal:  Transl Psychiatry       Date:  2019-11-11       Impact factor: 6.222

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.